Celebrating 20 years of innovation - Discover how we've been a catalyst for regional growth and UK innovation for over two decades in CPI's Annual Review 2023-2024.

CPI at TIDES USA: Oligonucleotide and Peptide Therapeutics

CPI at TIDES USA: Oligonucleotide and Peptide Therapeutics

Tue, 14 May 2024

Event Details

Start Date
Tue, 14 May 2024
End Date
Fri, 17 May 2024
Location
Boston, MA
Share This Page
Events

Speaker

Barrie Cassey - Medicines Manufacturing Technology Lead, CPI

Barrie Cassey

Medicines Manufacturing Technology Lead, CPI

A successful pharmaceutical and biotechnology technical leader with significant experience in a wide range of areas including process development, GMP manufacturing, technology transfer, and bringing innovation into commercial use. As a technically astute natural leader, Barrie has created and led teams from 1 to 100 whilst delivering complex and commercially critical projects.

Connect with Barrie on LinkedIn

Next steps


Oligonucleotides are a revolutionary new therapeutic in the pharma industry. These short, chemically synthesised fragments of DNA or RNA modulate protein expression through several different mechanisms to treat the underlying drivers of disease. 

They can cover a wide variety of diseases, from cancer to Alzheimer’s, and have the potential to unlock medicines for conditions currently considered untreatable and create more effective medicines for larger patient populations such as heart disease. 

Eager to find out more? I’d love to have a conversation about how we can work together.

To receive a copy of an introductory slide deck on the current Oligonucleotide projects currently underway at CPI, simply fill out the short form below.

CPI is your innovation partner to make your ideas a reality.